A qualitative evaluation of the process of creating and implementing an interprofessional care pathway for patients treated with oral anticancer drugs

Eur J Oncol Nurs. 2022 Dec:61:102218. doi: 10.1016/j.ejon.2022.102218. Epub 2022 Oct 4.

Abstract

Purpose: To investigate factors affecting the co-creation and implementation of care pathways for patients treated with oral anticancer drugs.

Methods: An explorative qualitative process evaluation was performed at four Belgian hospitals, co-creating and implementing a care pathway for patients on oral anticancer drugs. Semistructured interviews and focus groups were performed by a) local coordinators leading an interprofessional project team during the co-creation and implementation stage, b) external implementation coaches, and c) teams of healthcare professionals with a role in the care pathway. In total, 47 stakeholders were interviewed. Interviews were audio-taped, transcribed verbatim, and analyzed thematically.

Results: We found four factors affecting co-creation and implementation of care pathways for patients on oral anticancer drugs. Developing an adequate supporting context using motivated interprofessional project teams of clinical and management staff led by competent coordinators is one important facilitator. Leadership of local coordinators and oncologists is crucial for progressing the co-creation. Other factors included the complexity of the oral anticancer drug intervention, the interprofessional character of the care pathway, and involving primary care. External coaching during co-creation proved an important facilitator.

Conclusions: Prior investigation of willingness and motivation to change in clinical and management staff, competent coordinators, and leadership of oncologists are needed. In addition, external support determines the success of co-creating and implementing care pathways for patients on oral anticancer drugs.

Keywords: Barriers and facilitators; Care pathway; Complex intervention; Implementation; Interprofessional care; Oncology nursing; Oral anticancer drugs; Process evaluation; Seamless care.

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • Critical Pathways*
  • Focus Groups
  • Health Personnel
  • Humans
  • Qualitative Research

Substances

  • Antineoplastic Agents